25 Feb 2015

EarlySense Increases Presence in Asia with Regulatory Clearance and a New Distributor in S. Korea

Customize font size:

Ramat Gan, Israel, February 25, 2015 – EarlySense®, the market leader in contact-free monitoring solutions today announced receiving an approval to distribute the EarlySense System including the Bedside Monitor and Central Display System in the Korean Market. The Korean selling license and KGMP approval for EarlySense is another major regulatory milestone in a rapidly growing market that includes more than 50 million people with a high quality and rapidly growing healthcare system.

“The South Korean market shows great potential for the EarlySense solutions as they help provide superior patient care and safety levels for Caregivers and their Patients.” Said E.J.KIM, CEO Woo-Jin Meditec Korea “We have already received very positive responses from potential customers, and we are looking forward to implement the contact-free monitoring technology in various hospitals around Korea which include more than 550,000 beds.”

“This is another significant step in our strategy to expand EarlySense’s presence in growing markets in East Asia” Says Yfat Scialom, VP international Sales and Marketing “By utilizing EarlySense technology, hospitals in Korea will be able to provide the staff tools to detect patient deterioration early and to avoid adverse events such as patient falls and pressure ulcers”




South Korea’s medical market size in 2013 was around US $4.2B and grew by more than 7% between 2010 and 2013. The Korean health care system has several advantages that provide a strong platform for the contact-free monitoring technology: world-class information technology infrastructure and healthcare data, increasing demand for greater accountability and a recent focus on providing cost effective solution for an aging population with a growing chronic disease burden.


“We are excited to start operating in the South Korean market, as it has a strong focus on patient safety and quality of care”, said Dalia Argaman, VP of Clinical and Regulatory Affairs & QA of EarlySense. “This regulatory clearance is additional evidence for EarlySense’s robust quality system.”

About EarlySense

EarlySense is the market leader in contact-free and continuous monitoring for the medical and consumer wellness markets, with a unique sensor that is placed under the mattress and advanced analytics that leverage big data capabilities to provide unique offerings. The company’s solutions monitor heart and respiratory rate, as well as movement and sleep. EarlySense’s medical solutions for institution and home environments assist clinicians in early detection of patient deterioration and in identifying and preventing potential adverse events such as patient falls and pressure ulcers. EarlySense’s wellness solutions facilitate wellness and sleep improvement and are a key part of smart home solutions. EarlySense also offers OEM solutions for companies looking to expand their products by providing contact-free and continuous sensing capabilities. The company’s international headquarters are in Israel. The US headquarters are in Waltham, MA. The EarlySense System is currently installed in hospitals, rehabilitation centers and homes in USA, Europe, Asia and Australia.